ArticleFrontiers in pharmacology2023
Safety and risks of CBD oils purchased online: unveiling uncertain quality and vague health claims.
Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.
- The prevalence of cannabidiol (CBD) use in North America and Europe: A meta-analysis.Addiction (Abingdon, England) · 2026Pooled it
- Poorly labeled CBD and related cannabinoid oils marketed in Europe: a hidden risk for consumers? Insights from a long-term study.Analytical and bioanalytical chemistry · 2026Article
- Cannabidiol in Food and Food Supplements: Drug, Novel Food and Hazard Triangle.Molecules (Basel, Switzerland) · 2026Article
- Characterization of Women's Health Benefit Claims Made on Cannabis E-Commerce Platforms: A Retrospective Market Surveillance Study.American journal of preventive medicine · 2026Article
- Not what it seems: analytical validation and label accuracy of commercial CBD oils using HPTLC.Journal of cannabis research · 2026Article
- Evaluation of the unregulated online kratom market in two east-central European countries: test purchase and analysis of potential toxicological consequences.Harm reduction journal · 2025Article
- Exploratory analysis of United States-based cannabis product health benefit claims on online marketplaces.Addiction (Abingdon, England) · 2025Article
- Recent HPLC-UV Approaches for Cannabinoid Analysis: From Extraction to Method Validation and Quantification Compliance.Pharmaceuticals (Basel, Switzerland) · 2025Review
- Review
- Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study.Journal of medical Internet research · 2024Article
- Cannabis-Derived Product Types, Flavors, and Compound Types From an E-Commerce Website.JAMA network open · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.